The obese patient: Difference between revisions

(Text replacement - "pt's" to "patient's")
 
(13 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Definitions==
==Definitions==
*Overweight = BMI 25-29  
*BMI 25-29 = Overweight
*Obesity = BMI 30-39  
*BMI 30-39 = Obese
*Morbid obesity = BMI 40-49  
*BMI 40-49 = Morbidly obese
*Super obesity = BMI >50
*BMI >50 = Super obese


==Dosing Scalars==
==Dosing Scalars==
*Total body weight '''(TBW)'''= Actual weight  
*Total body weight '''(TBW)'''= Actual weight  
**May result in over dosing  
**May result in over dosing  
*Ideal body weight '''(IBW)'''= Calc. based on height & weight  
*[[ideal body weight estimation|Ideal body weight]] '''(IBW)'''= Calc. based on height & weight  
**May result in under dosing  
**May result in under dosing  
*Lean body weight '''(LBW)'''= Difference between TBW and fat mass<br>  
*Lean body weight '''(LBW)'''= Difference between TBW and fat mass<br>  
Line 15: Line 15:


===Estimating Patient Weight===
===Estimating Patient Weight===
Multiple formulas to estimate weight, below are most common:  
''There are multiple formulas to estimate weight - these are the most common:''


*'''Estimated male TBW''' = 93.2 + 3.29[arm circumference (cm)] + 0.43[height (cm)]  
*'''Estimated male TBW''' = 93.2 + 3.29[arm circumference (cm)] + 0.43[height (cm)]  
Line 35: Line 35:
''Obesity alters hepatic/renal clearance and volume of distribution (Vd) of many drugs''
''Obesity alters hepatic/renal clearance and volume of distribution (Vd) of many drugs''
{| class="wikitable"  
{| class="wikitable"  
|+ Medication Adjustment in Obesity  
|+ Medication Adjustment in Obesity<ref>Venkat A, Ingrande J, and Lemmens HJM. Challenging & Emerging Conditions in EM. Dose adjustment of anaesthetics in the morbidly obese. British journal of anaesthesia. 2010; 105(suppl 1):i16-i23.</ref>
|-
|-
| '''Medication'''  
| '''Medication'''  
| '''Dose Adjustment&nbsp;'''
| '''Dose Adjustment&nbsp;'''
|-
|-
| Morphine  
| [[Morphine]]
| Dose by IBW
| Dose by IBW
|-
|-
| Fentanyl  
| [[Fentanyl]]
| Dose by LBW; Alternative: Initial dose TBW, subsequent dose by IBW (risk over dose when use TBW)
| Dose by LBW; Alternative: Initial dose TBW, subsequent dose by IBW (risk over dose when use TBW)
|-
|-
| Midazolam  
| [[Midazolam]]
| Initial dose TBW, subsequent dose by IBW
| Initial dose TBW, subsequent dose by IBW
|-
|-
| Propofol&nbsp;  
| [[Propofol]]&nbsp;  
| Dose by LBW
| Dose by LBW
|-
|-
| Etomidate  
| [[Etomidate]]
| Dose by LBW
| Dose by LBW
|-
|-
| Succinylcholine
| [[Succinylcholine]]
| Dose by TBW @ 1mg/kg
| Dose by TBW @ 1mg/kg
|-
|-
| Rocuronium
| [[Rocuronium]]
| Dose by IBW
| Dose by IBW
|-
|-
| Heparin
| [[Heparin]]
| Same as non-obese pt (80U/kg followed by 18U/kg/h using TBW)
| Same as non-obese patient (80U/kg followed by 18U/kg/h using TBW)
|-
|-
| Vancomycin
| [[Vancomycin]]
| 30 mg/kg TBW (then follow serum levels)
| 30mg/kg TBW (then follow serum levels)
|-
|-
| Aminoglycosides
| [[Aminoglycosides]]
| Dose by ABW (C= 0.4; then follow serum levels)
| Dose by ABW (C= 0.4; then follow serum levels)
|-
|-
| Beta-lactams
| [[Beta-lactams]]
| No good data, may consider doubling dose
| No good data, may consider doubling dose
|-
|-
| Carbapenems
| [[Carbapenems]]
| No empiric change recommended
| No empiric change recommended
|-
|-
| Antifungals
| [[Antifungals]]
| No empiric change recommended; use LBW when dosing weight-based agents
| No empiric change recommended; use LBW when dosing weight-based agents
|}
|}


==Airway Management==  
==Airway Management==
Obesity associated with difficult bag-mask ventilation (BMV) and intubation
Obesity associated with difficult bag-mask ventilation ([[BVM]]) and intubation
* Consider prolonged pre-oxygenation period and two provider BMV
*Consider prolonged pre-oxygenation period and two provider BMV
* May improve lung function through use of pre-intubation period of NIPPV
*May improve lung function through use of pre-intubation period of [[NIPPV]]
** Obesity hypoventilation syndrome may cause chronic hypercapnia
**Obesity hypoventilation syndrome may cause chronic hypercapnia
* Place pt in "ramp" position
*Place patient in "ramp" position
** Stack blankets behind patient's back to horizontally align external auditory meatus with sternal notch
**Stack blankets behind patient's back to horizontally align external auditory meatus with sternal notch
* Consider Airtraq laryngoscope (shortened mean intubation time & desat episodes vs Mac DL in obese patients)
*Consider Airtraq laryngoscope (shortened mean intubation time & desat episodes vs Mac DL in obese patients) OR other hyperangulated video laryngoscope such as glidescope
* Increased BMI associated with higher rate of developing ARDS
*Increased BMI associated with higher rate of developing ARDS
** Methods to improve oxygenation/ventilation:
**Methods to improve oxygenation/ventilation:
*** Use PEEP 10 to improve oxygenation if needed  
***Use PEEP 10 to improve oxygenation if needed  
*** Place in reverse Trendelenburg ("beach chair" position) to improve ventilation
***Place in reverse Trendelenburg ("beach chair" position) to improve ventilation
*** Both may decrease CO so use cautiously in unstable patients
***Both may decrease CO so use cautiously in unstable patients


==[[Lumbar Puncture]]==
==[[Lumbar Puncture]]==
Obese patients have increased distance from skin to subarachnoid space
*Obese patients have increased distance from skin to subarachnoid space
* Upright pt positioning improves LP success
*Upright patient positioning improves LP success
* Estimated lumbar puncture depth (cm) = 1 + 17[weight(kg)/height(cm)]
*Estimated lumbar puncture depth (cm) = 1 + 17[weight(kg)/height(cm)]
* Ultrasound may improve the ID of landmarks
*Ultrasound may improve identification of landmarks
*If failure, consider fluoroscopy-guided procedure by IR


==References==
==References==
Challenging & Emerging Conditions in EM by A. Venkat, Ingrande, J., and H. J. M. Lemmens. "Dose adjustment of anaesthetics in the morbidly obese." British journal of anaesthesia 105.suppl 1 (2010): i16-i23.
<references/>


[[Category:Misc/General]]
[[Category:Misc/General]]

Latest revision as of 14:12, 13 October 2019

Definitions

  • BMI 25-29 = Overweight
  • BMI 30-39 = Obese
  • BMI 40-49 = Morbidly obese
  • BMI >50 = Super obese

Dosing Scalars

  • Total body weight (TBW)= Actual weight
    • May result in over dosing
  • Ideal body weight (IBW)= Calc. based on height & weight
    • May result in under dosing
  • Lean body weight (LBW)= Difference between TBW and fat mass
    • Technically best weight scalar for drug administration but difficult to accurately measure
  • Adjusted body weight (ABW) = Scalar derived from aminoglycoside pharmacokinetics (PK) in obesity

Estimating Patient Weight

There are multiple formulas to estimate weight - these are the most common:

  • Estimated male TBW = 93.2 + 3.29[arm circumference (cm)] + 0.43[height (cm)]
  • Estimated female TBW = 64.6 + 2.15[arm circumference (cm)] + 0.54[height (cm)]
  • Estimated male IBW in kg = height in cm - 100
    • More accurate IBW estimate:
      • IBW (male) in kg = 50kg + 2.3kg for each in. over 5ft
  • Estimated female IBW in kg = height in cm - 105
    • More accurate IBW estimate:
      • IBW (female) in kg = 45kg + 2.3kg for each in. over 5ft
  • Estimated LBW = 1.3 x IBW
  • Estimated ABW = IBW + [C x(TBW-IBW)]
    • C = correction factor ususally 0.2 to 0.4
  • Apps/Online resources:

Medication Adjustments in Obesity

Obesity alters hepatic/renal clearance and volume of distribution (Vd) of many drugs

Medication Adjustment in Obesity[1]
Medication Dose Adjustment 
Morphine Dose by IBW
Fentanyl Dose by LBW; Alternative: Initial dose TBW, subsequent dose by IBW (risk over dose when use TBW)
Midazolam Initial dose TBW, subsequent dose by IBW
Propofol  Dose by LBW
Etomidate Dose by LBW
Succinylcholine Dose by TBW @ 1mg/kg
Rocuronium Dose by IBW
Heparin Same as non-obese patient (80U/kg followed by 18U/kg/h using TBW)
Vancomycin 30mg/kg TBW (then follow serum levels)
Aminoglycosides Dose by ABW (C= 0.4; then follow serum levels)
Beta-lactams No good data, may consider doubling dose
Carbapenems No empiric change recommended
Antifungals No empiric change recommended; use LBW when dosing weight-based agents

Airway Management

Obesity associated with difficult bag-mask ventilation (BVM) and intubation

  • Consider prolonged pre-oxygenation period and two provider BMV
  • May improve lung function through use of pre-intubation period of NIPPV
    • Obesity hypoventilation syndrome may cause chronic hypercapnia
  • Place patient in "ramp" position
    • Stack blankets behind patient's back to horizontally align external auditory meatus with sternal notch
  • Consider Airtraq laryngoscope (shortened mean intubation time & desat episodes vs Mac DL in obese patients) OR other hyperangulated video laryngoscope such as glidescope
  • Increased BMI associated with higher rate of developing ARDS
    • Methods to improve oxygenation/ventilation:
      • Use PEEP 10 to improve oxygenation if needed
      • Place in reverse Trendelenburg ("beach chair" position) to improve ventilation
      • Both may decrease CO so use cautiously in unstable patients

Lumbar Puncture

  • Obese patients have increased distance from skin to subarachnoid space
  • Upright patient positioning improves LP success
  • Estimated lumbar puncture depth (cm) = 1 + 17[weight(kg)/height(cm)]
  • Ultrasound may improve identification of landmarks
  • If failure, consider fluoroscopy-guided procedure by IR

References

  1. Venkat A, Ingrande J, and Lemmens HJM. Challenging & Emerging Conditions in EM. Dose adjustment of anaesthetics in the morbidly obese. British journal of anaesthesia. 2010; 105(suppl 1):i16-i23.